Enhancing the synergy of in-vivo multimodal brain imaging

增强体内多模式脑成像的协同作用

基本信息

  • 批准号:
    RGPIN-2019-04232
  • 负责人:
  • 金额:
    $ 6.92万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2021
  • 资助国家:
    加拿大
  • 起止时间:
    2021-01-01 至 2022-12-31
  • 项目状态:
    已结题

项目摘要

Background. Brain illness is considered the major health challenge in the 21st century; knowledge on brain function and disease mechanisms is still limited. Non-invasive brain imaging has fundamentally contributed to the current understanding of brain function, which depicts the brain as a series of networks. Neurodegenerative diseases are hypothesized to induce pathological alterations within specific networks, considered to be mediated by molecular pathology. Multi-modality (hybrid) imaging comprising simultaneous Positron Emission Tomography (PET) and magnetic resonance imaging (MRI), is particularly well suited to explore this hypothesis by investigating neurochemical correlates (PET) of the disease-associated structural and connectivity alterations (MRI). While the hardware compatibility of PET and MRI is fairly mature, data acquisition protocols and analysis methods to maximize the synergy of hybrid imaging still need to be developed. Goal. To develop algorithms aimed at enhancing the synergy of hybrid PET/MRI for brain imaging with three inter-related aims: (i) improving PET image quality; (ii) developing accurate measurements of novel multi-modality metrics related to fundamental aspects of brain function, such as energetics and interactions between neurotransmitter activity and brain functional/structural networks (iii) developing methods to quantify interactions between metabolic, functional and structural networks and disease specific multi-parameter features that could serve as disease biomarkers. Methods. The following will be developed: (i) Data denoising to improve the PET temporal resolution to make it more commensurate with MRI; (ii.a) Simultaneous calibrated BOLD (MRI) and dynamic glucose uptake (PET) measurements to obtain simultaneous separate estimates of cerebral blood flow, oxygen extraction fraction and cerebral oxygen and glucose metabolic rates. These measurements will be combined with algorithms developed under aim 3 to yield estimates of the novel metrics listed above; (ii.b) Estimation of stimuli-induced transient neurotransmitter release (PET) coupled with its effect on brain connectivity and signaling (MRI); (iii) Canonical correlation analysis, orthogonal signal correction, consensus clustering, hypergraph learning and multilayer graph analyses to extract common and unique patterns from the multimodal data and advanced statistical or machine-learning based clustering algorithm to extract relevant features. Impact. This program reflects technological and conceptual advancements in instrumentation and brain research. While some proposed methods are not intrinsically original, the novelty and significance result from selectively adapting them to hybrid imaging; they will (i) enable exploration and quantification of fundamental aspects of brain function such as brain energetics, thus opening new research avenues and (ii) maximize the investigative power of hybrid imaging also applicable to other research fields.
背景脑疾病被认为是21世纪世纪的主要健康挑战;对脑功能和疾病机制的认识仍然有限。非侵入性脑成像从根本上促进了目前对大脑功能的理解,将大脑描绘为一系列网络。神经退行性疾病被假设为诱导特定网络内的病理改变,被认为是由分子病理学介导的。多模态(混合)成像包括同时的正电子发射断层扫描(PET)和磁共振成像(MRI),特别适合于通过研究疾病相关的结构和连接性改变(MRI)的神经化学相关物(PET)来探索该假设。虽然PET和MRI的硬件兼容性相当成熟,但仍需要开发最大化混合成像协同作用的数据采集协议和分析方法。目标.开发旨在增强混合PET/MRI用于脑成像的协同作用的算法,具有三个相互关联的目标:(i)提高PET图像质量;(ii)开发与脑功能的基本方面相关的新的多模态度量的精确测量,例如神经递质活动和脑功能/结构网络之间的能量学和相互作用(iii)开发量化代谢,功能和结构网络以及可以用作疾病生物标志物的疾病特异性多参数特征。 方法.将开发以下内容:(i)数据去噪,以提高PET时间分辨率,使其与MRI更相称;(ii. a)同时校准BOLD(MRI)和动态葡萄糖摄取(PET)测量,以同时单独估计脑血流量、氧提取分数以及脑氧和葡萄糖代谢率。这些测量将与根据目标3开发的算法相结合,以得出上述新指标的估计值;(ii.B)估计刺激诱导的瞬时神经递质释放(PET)及其对脑连接和信号传导的影响(MRI);(iii)典型相关分析、正交信号校正、一致聚类,超图学习和多层图分析,以从多模态数据中提取共同和独特的模式,以及先进的基于统计或机器学习的聚类算法,以提取相关特征。冲击该计划反映了仪器和大脑研究的技术和概念进步。虽然提出的一些方法本质上不是原创的,但其新奇和重要性来自于选择性地使其适应混合成像;它们将(i)使大脑功能的基本方面(如大脑能量学)的探索和量化成为可能,从而开辟新的研究途径,(ii)最大限度地提高混合成像的研究能力,也适用于其他研究领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sossi, Vesna其他文献

Serotonergic System Impacts Levodopa Response in Early Parkinson's and Future Risk of Dyskinesia
  • DOI:
    10.1002/mds.28340
  • 发表时间:
    2020-10-22
  • 期刊:
  • 影响因子:
    8.6
  • 作者:
    Fu, Jessie F.;Matarazzo, Michele;Sossi, Vesna
  • 通讯作者:
    Sossi, Vesna
Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
  • DOI:
    10.1016/j.nicl.2016.02.012
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Rahmim, Arman;Salimpour, Yousef;Jain, Saurabh;Blinder, Stephan A. L.;Klyuzhin, Ivans S.;Smith, Gwenn S.;Mari, Zoltan;Sossi, Vesna
  • 通讯作者:
    Sossi, Vesna
Use of Generative Disease Models for Analysis and Selection of Radiomic Features in PET
Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
  • DOI:
    10.1186/2191-219x-3-69
  • 发表时间:
    2013-01-01
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Walker, Matthew D.;Dinelle, Katherine;Sossi, Vesna
  • 通讯作者:
    Sossi, Vesna
Performance of a PET Insert for High-Resolution Small-Animal PET/MRI at 7 Tesla
  • DOI:
    10.2967/jnumed.116.187666
  • 发表时间:
    2018-03-01
  • 期刊:
  • 影响因子:
    9.3
  • 作者:
    Stortz, Greg;Thiessen, Jonathan D.;Sossi, Vesna
  • 通讯作者:
    Sossi, Vesna

Sossi, Vesna的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sossi, Vesna', 18)}}的其他基金

Enhancing the synergy of in-vivo multimodal brain imaging
增强体内多模式脑成像的协同作用
  • 批准号:
    RGPIN-2019-04232
  • 财政年份:
    2022
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Enhancing the synergy of in-vivo multimodal brain imaging
增强体内多模式脑成像的协同作用
  • 批准号:
    RGPIN-2019-04232
  • 财政年份:
    2020
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Enhancing the synergy of in-vivo multimodal brain imaging
增强体内多模式脑成像的协同作用
  • 批准号:
    RGPIN-2019-04232
  • 财政年份:
    2019
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Quantitative high resolution in-vivo multi-modality medical imaging techniques
定量高分辨率体内多模态医学成像技术
  • 批准号:
    240670-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Quantitative high resolution in-vivo multi-modality medical imaging techniques
定量高分辨率体内多模态医学成像技术
  • 批准号:
    240670-2013
  • 财政年份:
    2016
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Quantitative high resolution in-vivo multi-modality medical imaging techniques
定量高分辨率体内多模态医学成像技术
  • 批准号:
    240670-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Quantitative high resolution in-vivo multi-modality medical imaging techniques
定量高分辨率体内多模态医学成像技术
  • 批准号:
    240670-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Quantitative high resolution in-vivo multi-modality medical imaging techniques
定量高分辨率体内多模态医学成像技术
  • 批准号:
    240670-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
An interactive 3D interface for personalized, mobile-based system for skin cancer screening
用于个性化、基于移动的皮肤癌筛查系统的交互式 3D 界面
  • 批准号:
    461390-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Engage Grants Program
Quantitative high resolution PET imaging humans and small animals
人类和小动物的定量高分辨率 PET 成像
  • 批准号:
    240670-2004
  • 财政年份:
    2012
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual

相似海外基金

Mechanisms of Synergy between Oncolytic Herpes Simplex Virus and Trabectedin in Pediatric Bone Sarcomas
溶瘤单纯疱疹病毒与曲贝替定治疗小儿骨肉瘤的协同作用机制
  • 批准号:
    10607503
  • 财政年份:
    2023
  • 资助金额:
    $ 6.92万
  • 项目类别:
Generation of highly differentiated NK cells to act in synergy with broadly neutralizing antibodies to reduce the SIV reservoir and establish viral control in absence of ART
生成高度分化的 NK 细胞,与广泛中和抗体协同作用,减少 SIV 储存库,并在没有 ART 的情况下建立病毒控制
  • 批准号:
    10883005
  • 财政年份:
    2023
  • 资助金额:
    $ 6.92万
  • 项目类别:
Genetic determinants of bacterial-drug synergy against Candida
对抗念珠菌的细菌-药物协同作用的遗传决定因素
  • 批准号:
    10584713
  • 财政年份:
    2022
  • 资助金额:
    $ 6.92万
  • 项目类别:
Enhancing the synergy of in-vivo multimodal brain imaging
增强体内多模式脑成像的协同作用
  • 批准号:
    RGPIN-2019-04232
  • 财政年份:
    2022
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Discovery Grants Program - Individual
Intraspinal circuits supporting synergy between the bladder and urethral sphincter in mice
支持小鼠膀胱和尿道括约肌协同作用的椎内回路
  • 批准号:
    10458072
  • 财政年份:
    2021
  • 资助金额:
    $ 6.92万
  • 项目类别:
Synergy of lipolysis and lipophagy in alcoholic liver disease
脂肪分解和脂肪吞噬在酒精性肝病中的协同作用
  • 批准号:
    10489818
  • 财政年份:
    2021
  • 资助金额:
    $ 6.92万
  • 项目类别:
Intraspinal circuits supporting synergy between the bladder and urethral sphincter in mice
支持小鼠膀胱和尿道括约肌协同作用的椎内回路
  • 批准号:
    10662280
  • 财政年份:
    2021
  • 资助金额:
    $ 6.92万
  • 项目类别:
Exploring detailed mechanism of in vivo superlubricity exerted by synergy of highly-hydrated soft matter and biological molecules including hyaluronan, lipids and proteins
探索高水合软物质与透明质酸、脂质和蛋白质等生物分子协同作用产生体内超润滑性的详细机制
  • 批准号:
    21H04535
  • 财政年份:
    2021
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synergy of lipolysis and lipophagy in alcoholic liver disease
脂肪分解和脂肪吞噬在酒精性肝病中的协同作用
  • 批准号:
    10455130
  • 财政年份:
    2021
  • 资助金额:
    $ 6.92万
  • 项目类别:
Elucidating Synergy of Enzalutamide and Src Kinase Inhibitors in Castration-Resistant Prostate Cancer
阐明恩杂鲁胺和 Src 激酶抑制剂在去势抵抗性前列腺癌中的协同作用
  • 批准号:
    10476997
  • 财政年份:
    2021
  • 资助金额:
    $ 6.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了